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Perial Angiographic Follow-Up
f Sirolimus-Eluting Stents for Unprotected
eft Main Coronary Artery Revascularization
atthew J. Price, MD, FACC,* Ecaterina Cristea, MD,† Neil Sawhney, MD,* John A. Kao, MD, FACC,*
effrey W. Moses, MD, FACC,† Martin B. Leon, MD, FACC,† Ricardo A. Costa, MD,†
lexandra J. Lansky, MD, FACC,† Paul S. Teirstein, MD, FACC*
a Jolla, California; and New York, New York
OBJECTIVES This study was performed to evaluate the clinical and serial angiographic outcomes of patients
undergoing sirolimus-eluting stent (SES) implantation for unprotected left main coronary
artery (LMCA) stenosis.
BACKGROUND The efficacy of SES has led to their expanded use for off-label indications, including LMCA
disease.
METHODS Unprotected LMCA intervention with SES was attempted in 50 patients. Surveillance
angiography was performed at three and nine months’ follow-up.
RESULTS The target lesion involved the distal LMCA in 47 patients (94%). In-lesion restenosis
occurred in 21 patients (42%), was focal in 85% of cases, and in 82% involved the branch ostia,
sparing the LMCA itself. Target lesion revascularization (TLR) occurred in 19 patients
(38%) over a mean follow-up of 276  57 days; TLR was ischemia-driven in 7 patients
(14%). Late loss was significantly greater within the left circumflex (LCX) ostium compared
to the parent vessel (PV) of the LMCA bifurcation (0.83  0.89 mm vs. 0.49  0.72 mm,
p  0.04). Late loss continued to increase between three- and nine-month follow-up. Final
minimal luminal diameter and maximal balloon pressure were independent predictors of
restenosis of the PV.
CONCLUSIONS Restenosis is a frequent finding when serial angiographic follow-up is performed after SES
implantation for unprotected distal LMCA lesions. Restenosis is usually focal, most often
involves the LCX ostium, and often occurs without symptoms. (J Am Coll Cardiol 2006;
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.12.01547:871–7) © 2006 by the American College of Cardiology Foundation
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the accepted treatment of unprotected left main coronary
rtery (LMCA) disease is coronary artery bypass surgery
CABG). The approval of sirolimus-eluting stents (SES)
as increasingly led to their off-label use in this patient
opulation despite the absence of randomized data support-
ng its efficacy (1). The goal of this study was to evaluate the
erial angiographic outcomes of consecutive patients at our
nstitution who underwent SES implantation for unpro-
ected LMCA stenosis.
See page 878
ETHODS
atient selection and study population. All patients who
nderwent elective, urgent, or emergent placement of SES
or lesions within the unprotected LMCA at Scripps Clinic
etween February 2003 and July 2004 were included in this
From the *Division of Cardiovascular Disease, Scripps Clinic, La Jolla, California;
Columbia University Medical Center and Cardiovascular Research Foundation,
ew York, New York; and ‡. Dr. Moses is a consultant for and stock shareholder of
ohnson & Johnson. Dr. Leon is a stock shareholder of Johnson & Johnson. Dr.
ansky receives research grants from Johnson & Johnson. Dr. Teirstein receives
oyalties and research grants from Johnson & Johnson.L
Manuscript received July 27, 2005; revised manuscript received October 25, 2005,
ccepted October 31, 2005.nalysis. During this time period, implantation of SES
ollowed by serial angiography was the default approach for
ercutaneous LMCA intervention. Patients were consid-
red eligible for percutaneous LMCA intervention if they
ere deemed to be a high surgical risk by a cardiac surgeon
r if they refused CABG despite the recommendations of a
ardiac surgeon, and agreed to return for surveillance an-
iography at three and nine months to exclude restenosis.
rocedure. Patients not previously taking clopidogrel were
oaded with 300 mg or 600 mg before the procedure or at
he conclusion of the procedure before leaving the catheter-
zation laboratory. Either intraprocedural heparin (with a
oal activated clotting time of 250 s) or bivalirudin was
dministered during the procedure. All patients were in-
tructed to take daily aspirin 325 mg and clopidogrel 75 mg
ndefinitely.
One of three treatment techniques were used for lesions
nvolving the LMCA bifurcation: 1) “kissing stents” where
wo stents were simultaneously deployed across the ostia of
he left anterior descending (LAD) and left circumflex
LCX) arteries with proximal overlap within the body of
he LMCA; 2) “crush” stenting, in which the stent within
he side branch (usually, the LCX) was deployed first, and
hen the proximal portion of this stent projecting within the
MCA was “crushed” by deployment of the stent within
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SES Implantation for Unprotected Left Main Stenosis February 21, 2006:871–7he parent vessel; and 3) “rescue” stenting where a single
tent was deployed from the left main across the ostium of
ither the LAD or LCX with subsequent balloon angio-
lasty of the side branch if needed. Generally, operators
erformed “kissing stents” when there was disease within
he ostium of an LCX of significant caliber, “crush” stenting
hen there was disease within the ostium of an LCX of
maller caliber, and “rescue” stenting when there was no
isease within the LCX or if the LCX was diminutive.
ntra-aortic balloon counterpulsation, glycoprotein IIb/IIIa
se, and intravascular ultrasound (IVUS) were used at the
iscretion of the operator.
Serial cardiac enzymes (creatine kinase and CK-MB)
ere drawn every 12 h post-intervention until discharge.
ollow-up angiography was performed at three and nine
onths, or earlier for symptoms of ischemia. Routine stress
esting was not performed.
ngiographic methods. Quantitative coronary angiogra-
hy was performed by an off-site, independent core labora-
ory (Cardiovascular Research Foundation, New York, New
ork) using a validated edge-detection program (Cardio-
ascular Measurement System, Medis Medical Imaging
ystems, Nuenen, the Netherlands). For purposes of bifur-
ation analysis, the LMCA of every patient was divided into
he parent vessel and side branch. By convention, the parent
essel was defined as the LMCA and proximal LAD, and
he side branch as the LCX. The target lesion was defined
s involving the distal LMCA if it was within 3 mm of the
ranch ostia. For the parent vessel and side branch, the
eference vessel diameter (RVD), minimal luminal diameter
MLD), acute luminal gain (MLD immediately after the
rocedure minus the MLD before the procedure), binary
estenosis (stenosis of 50% of the luminal diameter),
ercent diameter stenosis, and late luminal loss (MLD
mmediately after the procedure minus the MLD at follow-
p) were measured separately. In-stent restenosis was de-
ned as within the stented segment and in-lesion restenosis
s spanning the stented segment plus the 5-mm proximal
nd distal peristent area (edges).
nd points and definitions. The LMCA was defined as
Abbreviations and Acronyms
CABG  coronary bypass surgery
DES  drug-eluting stents
IVUS  intravascular ultrasound
LAD  left anterior descending coronary artery
LCX  left circumflex artery
LMCA  left main coronary artery
MACE  major adverse cardiac events
MI  myocardial infarction
MLD  minimal luminal diameter
PCI  percutaneous coronary intervention
RVD  reference vessel diameter
SES  sirolimus-eluting stent
TLR  target lesion revascularizationunprotected” if there was no history of CABG, if CABG Had been performed and no grafts to the left coronary
ystem were patent, or if CABG had been performed to the
ight coronary artery only. Non–Q-wave myocardial infarc-
ion (MI) was defined as creatine kinase greater than two
imes the upper limit of normal with an abnormal CK-MB
n the absence of pathological Q waves. Stent thrombosis
as defined as any of the following: angiographic demon-
tration of stent closure or intrastent thrombus, unexplained
udden death, or MI without concomitant documentation
f a patent stent. Acute stent thrombosis was defined as
hrombosis occurring within 24 h, subacute thrombosis
etween 24 h and 30 days, and late thrombosis more than
0 days after the index procedure. Target lesion revascular-
zation (TLR) was defined as any repeat intervention
surgical or percutaneous) to treat a stenosis anywhere
ithin the LMCA or within 10 mm distal to the LAD and
CX ostia. Target lesion revascularization was further
haracterized as “ischemia-driven” if signs or symptoms of
schemia were present. Major adverse cardiac events
MACE) were defined as any MI, any TLR, thrombosis, or
eath. Technical success was defined as a final diameter
tenosis 30% and Thrombolysis In Myocardial Infarction
TIMI) flow grade 3.
Each patient’s pre-procedure cardiac surgical operative
ortality risk at 30 days was estimated post-hoc by using a
isk scoring system (the EuroSCORE) (2,3). “High-risk”
as defined as an estimated operative mortality of 5%.
tatistical methods. The computer-based analysis pro-
ram SPSS (Statistical Package for the Social Sciences, 10.1
or PC, SPSS Inc., Chicago, Illinois) was used for statistical
alculations. The chi-square test, or Fisher exact test when
ny expected cell count was 5 for a 2  2 table, was used
o detect differences in categorical variables; p  0.05 was
onsidered significant. Comparison of continuous variables was
erformed using Student t tests. Multiple logistic regression
nalysis (forward conditional) was applied to estimate the
ssociation between the proposed risk factors and each of
he outcomes (all-cause death, non-cardiac death, TLR,
I, parent vessel restenosis, side branch restenosis, and in-
nd out-of-hospital major adverse coronary events). Risk
actors included age, gender, hypertension, diabetes, periph-
ral vascular disease, prior MI, left ventricular ejection
raction40%, creatinine clearance45 ml/min (according
o the Cockroft-Gault formula), high cardiac surgery risk,
on-elective procedure, in-stent restenosis target lesion,
ngiographic calcification, stenting of both limbs of the
MCA bifurcation, kissing stents, “crush” stenting, use of
VUS post-stent deployment, use of intra-aortic balloon
ounterpulsation, RVD, final MLD, and the maximal
alloon dilation pressure. Kaplan-Meier survival functions
ere analyzed and graphed using Prophet (version 5.0, Bolt,
eranek, and Newman, Inc., sponsored by the National
enter for Research Resources of the National Institutes of
ealth).
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February 21, 2006:871–7 SES Implantation for Unprotected Left Main StenosisThe study protocol was approved by the Scripps Clinic
nstitutional Review Board, and appropriate informed con-
ent was obtained.
ESULTS
aseline characteristics. A total of 50 patients underwent
ttempted percutaneous intervention of the unprotected
MCA with SES. Patient and procedural characteristics are
isted in Table 1. Patients were predominantly at high risk
or cardiac surgery, with 58% having an estimated Euro-
CORE operative mortality of 5%. The procedure was
lective for stable angina or ischemia in 33 patients (66%),
nd was urgent or emergent in 17 patients (34%) (13
atients with unstable angina or non–ST-segment elevation
I, one patient with ST-segment elevation MI, two pa-
ients for “bailout” of iatrogenic left main dissection, and
ne patient with acute closure after diagnostic IVUS).
ardiogenic shock was present in four patients (8%). The
arget lesion involved the distal LMCA in 47 patients
94%). The lesion type was de novo atherosclerosis in 43
atients (86%), in-stent restenosis within bare metal stents
n 5 patients (10%) (2 of whom had failed prior intracoro-
ary radiation therapy), and iatrogenic LMCA dissection in
patients (4%). The average lesion length was 14.9 
.3 mm, pre-procedural TIMI flow grade was 3 in 3
atients (6%), and moderate-to-severe calcification was
resent in 14 patients (28%). Procedural characteristics are
hown in Table 2. No patient received rotational or direc-
ional coronary atherectomy.
n-hospital outcomes. Technical success was achieved in
ll patients. There were no in-hospital deaths. Acute stent
hrombosis occurred in two patients (4%), resulting in a
on–Q-wave MI in one patient and a Q-wave MI in the
econd. Both episodes of thrombosis occurred within 12 h
f “kissing stents” within the distal LMCA. One of these
atients failed to receive periprocedural clopidogrel loading
ue to a miscommunication regarding his medication status.
either patient received intraprocedural glycoprotein IIb/
IIa inhibitors. Repeat revascularization with balloon angio-
lasty was successful in both patients. A third patient
nderwent TLR (total in-hospital TLR  6%) for residual
MCA stenosis outside the previously stented segment that
able 1. Baseline Clinical Characteristics
Characteristic (n  50)
ean age (yrs) 69  13
ale 32 (64%)
iabetes mellitus 13 (26%)
eft ventricular ejection fraction 40% 12 (24%)
eripheral vascular disease 12 (24%)
reatinine clearance 45 ml/h 8 (16%)
rior myocardial infarction 18 (36%)
rior cardiac bypass surgery 5 (10%)
rior percutaneous coronary intervention 29 (58%)
ypertension 35 (70%)
rior stroke 5 (10%)alues are mean  SD or n (%).
*as noted during a planned staged percutaneous coronary
ntervention (PCI) of the right coronary artery before
ospital discharge. The combined end point of death, any
I, TLR, or thrombosis occurred more frequently in
on-elective compared to elective cases (4 of 17 [24%] vs. 1
f 33 [3%], p  0.04 by Fisher exact test.) The average
ospital stay post-procedure was 2.7  4.0 days (median 1
ay, range 1 to 24 days).
linical follow-up. Clinical events at follow-up are shown
n Table 3. Clinical follow-up was 100% over a median of
able 2. Procedural Characteristics
Characteristic (n  50)
echnique
Both LMCA branches stented 42 (84%)
“Kissing stents” 34 (68%)
“Crush”stenting 8 (16%)
Post-“crush” kissing PTCA 4 (8%)
Single SES across branch ostium 4 (8%)
POBA of side branch 2 (4%)
SES in LMCA, sparing bifurcation 4 (8%)
ntra-aortic balloon pump 29 (58%)
ivalirudin used 18 (36%)
lycoprotein IIb/IIIa used 11 (22%)
VUS post-stent deployment 26 (52%)
ostdilation with additional balloon 23 (46%)
ax inflation pressure, PV (atm) 17.4  1.9
ax inflation pressure, LCX (atm) 16.6  2.8
ax balloon size, PV (mm) 3.31  0.38
ax balloon size, LCX (mm) 3.05  0.38
tent size, PV (mm) 3.19  0.28
tent size, LCX (mm) 3.05  0.35
tent length, PV (mm) 18.4  7.2
tent length, LCX (mm) 17.8  6.7
CI of non-target lesion 35 (70%)
umber of stents per procedure 3.3  1.9
alues are mean  SD or n (%).
IVUS  intravascular ultrasound; LCX  left circumflex artery; LMCA  left
ain coronary artery; PCI percutaneous coronary intervention; POBA plain-old
alloon angioplasty; PV  parent vessel of the left main bifurcation (LMCA-
roximal left anterior descending); SES  sirolimus-eluting stent.
able 3. Early and Late Clinical Events
(n  50)
n-hospital events*
Death 0
MI 4 (8%)
Non–Q-wave 3 (6%)
Q-wave 1 (2%)
Acute thrombosis 2 (4%)
TLR 3 (6%)
Death, any MI, TLR, or thrombosis 5 (10%)
vents out-of-hospital over follow-up*
Death 5 (10%)
Cardiac death 1 (2%)
Non-cardiac death 4 (8%)
Subacute thrombosis 0
MI 1 (2%)
TLR 19 (38%)
TLR: ischemic driven 7 (14%)
Death, any MI, TLR, or thrombosis 22 (44%)More than one event occurred in some patients.
MI  myocardial infarction; TLR  target lesion revascularization.
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SES Implantation for Unprotected Left Main Stenosis February 21, 2006:871–781 days (range, 144 to 391 days). There was one episode of
ut-of-hospital non–Q-wave MI. Out-of-hospital TLR
ccurred in a total of 19 patients (38%); of these, only 7
atients (14%) had ischemia-driven TLR. The target lesion
ad been treated with bifurcation stenting in 18 of the 19
atients undergoing repeat revascularization. Of the eight
atients treated with crush stenting, TLR occurred in three
f the five that had final kissing-balloon post-dilation and
wo of the three that did not. There were no significant
ifferences in TLR between elective and non-elective cases
overall TLR, 12 of 33 [36%] vs. 7 of 17 [41%], p  NS by
hi-square test; ischemic TLR, 5 of 33 [14%] vs. 2 of 17
15%], p  NS by Fisher exact test), or between de novo
nd non-de novo lesions (overall TLR, 17 of 43 [39%] vs. 2
f 7 [29%], p  NS by Fisher exact test; ischemic TLR, 6
f 43 [14%] vs. 1 of 7 [14%], p  NS by Fisher exact test).
There were five deaths, four non-cardiac and one cardiac.
he combined end point of out-of-hospital MACE oc-
urred in 22 patients (44%). Kaplan-Meier survival free of
ACE is shown in Figure 1.
uantitative coronary angiography. Baseline and
ollow-up angiographic results are shown in Table 4. Over-
ll, follow-up angiography was performed on 49 patients
98%), and was of suitable quality for quantitative coronary
ngiography in 48 patients. Three-month follow-up an-
iography was complete in 47 patients (94%) at a median of
8 days (range, 44 to 199 days). Nine-month angiography
as complete in 31 patients (90% of patients alive and
ithout repeat revascularization at the 3-month follow-up)
t a median of 287 days (range, 165 to 447 days). In-lesion
estenosis was present in 21 patients (44%) and was focal
Mehran classification I) (4) in 85% of cases, with an
verage lesion length of 6.1  2.1 mm. The distribution of
estenosis is shown in Table 5. Restenosis was most frequent
ithin the left circumflex ostium, and occurred within the
MCA itself in only four patients (8%). In-stent late loss was
ignificantly greater within the LCX side branch compared toigure 1. Kaplan-Meier analysis of survival free of out-of-hospital major
dverse cardiac events over follow-up. Lhe parent vessel of the LMCA bifurcation (0.83  0.89 mm
s. 0.49  0.72 mm, p  0.04). Restenosis developed in five
atients (10%) between the three- and nine-month follow-
p; the in-stent late loss between three- and nine-month
urveillance angiography in patients without TLR at the
hree-month follow-up was 0.22  0.66 mm in the parent
essel and 0.41  0.71 mm in the LCX ostium.
ultivariate analysis. Multivariate predictors of outcomes
re listed in Table 6. There were no significant predictors of
n-hospital MACE. Creatinine clearance 45 ml/h was
ssociated with out-of-hospital TLR, death, and MACE.
iabetes mellitus tended to be associated with parent vessel
estenosis (p 0.052). Maximal balloon pressure within the
arent vessel and final MLD of the parent vessel were
ndependent predictors of parent vessel restenosis, while
here were no independent predictors of LCX restenosis.
ISCUSSION
he major finding of our study is that PCI of the unprotected
MCA with SES is feasible and relatively safe, but is limited
y frequent restenosis, most often involving the left circumflex
stium. In our series of consecutive patients with predomi-
antly distal left main disease and mandated, serial angio-
able 4. Quantitative Coronary Angiography Results
LMCA-LAD* LCX
esion length (mm) 14.9  6.3 10.5  4.6
VD (mm)
Pre-procedure (n  50) 2.9  0.7 2.7  0.6
LD (mm)
Pre-procedure (n  50) 1.19  0.60 1.30  0.57
Post-procedure (n  50) 2.87  0.47 2.70  0.42
3-month follow-up (n  46) 2.55  0.78 2.18  0.89
9-month follow-up† (n  48) 2.38  0.91 1.75  0.83
iameter stenosis (%)
Pre-procedure 62.1  18.2 54.5  17.8
Post-procedure 11.1  10.8 8.1  7.4
3-month follow-up 19.5  23.6 25.4  27.5
9-month follow-up 22.7  27.3 35.1  33.1
ate luminal loss (mm)
In-lesion, 3-month 0.34  0.58 0.44  0.61
In-stent, 3-month 0.33  0.61 0.52  0.76
In-lesion, 9-month 0.45  0.67 0.66  0.77
In-stent, 9-month 0.48  0.72 0.83  0.89
inary restenosis (%)
3-month follow-up 6/46 (13%) 13/46 (28%)
9-month follow-up 11/48 (23%) 17/48 (35%)
Bifurcation analysis was performed for every left main lesion. By convention, the
arent vessel of the bifurcation was defined as the left main into the left anterior
escending artery. †Two patients had follow-up at 9 months’ post-procedure only.
MLD  minimal luminal diameter; RVD  reference vessel diameter; other
bbreviations as in Table 2.
able 5. Distribution of Angiographic In-Stent Restenosis
Site n  21
MCA  branch ostia 4 (19%)
AD ostium only 2 (9.5%)
CX ostium only 10 (48%)
oth LAD, LCX ostia 5 (24%)AD  left anterior descending artery; other abbbreviations as in Table 2.
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February 21, 2006:871–7 SES Implantation for Unprotected Left Main Stenosisraphic surveillance, the rate of TLR was 38% and the rate of
estenosis was 44% over a median follow-up of 9.2 months.
We observed higher revascularization and restenosis rates
han previously reported for drug-eluting stent (DES)
ntervention within the LMCA (5–8). This may be due to
ur high rate of angiographic follow-up in combination
ith the large proportion of patients undergoing LMCA
ifurcation stenting in our study. The rate of mandated
ollow-up angiography in previously reported series was
uite low, generally under 50%. While one study reported a
ollow-up angiography rate of 84%, in that study, only 40%
f patients had bifurcation stenting (5,7,8). In comparison,
ur angiographic follow-up was nearly complete (98%), and
very large proportion of patients (84%) had stenting of
oth limbs of the LMCA bifurcation. In our study, TLR
as performed for signs or symptoms of ischemia in only
even patients, resulting in a “clinical” ischemia-driven TLR
ate of only 14%. Therefore, our high revascularization rate
ay have been due to the “oculostenotic reflex” in response
o asymptomatic left main or ostial major branch vessel
isease uncovered during surveillance angiography. Al-
hough such lesions may jeopardize a large amount of
yocardium, the benefit of revascularization in this setting
as not been proven. While the clinical appropriateness of
ur approach remains unanswered by this study, we believe
hat the low revascularization rates observed in previous
tudies with clinical follow-up alone (7) underestimate the
ctual number of patients with DES failure after LMCA
ntervention. The anatomic pattern of restenosis we
bserved—focal in 85% of cases and involving only the
ranch ostia in 81%—is consistent with previous reports
6,9). Therefore, while failure is frequent, it occurs uncom-
only within the LMCA itself, and is usually amenable to
epeat revascularization using a percutaneous approach.
Our disappointing results may also be due to the large
roportion of lesions involving the distal left main that were
reated with bifurcation stenting. Distal left main stenosis
as been shown to be associated with adverse events after
Table 6. Multivariate Analysis of Candidate P
End Point Predictor Variable
Out-of-hospital TLR CrCl 45 ml/min
Max atm PV
Out-of-hospital MACE CrCl 45 ml/min
Crush stenting
Death CrCl 45 ml/min
Restenosis of parent vessel‡ Max atm PV
Final MLD, PV
Diabetes
*Multivariate analysis was performed for the following predict
disease, prior myocardial infarction, left ventricular ejection
cardiac surgery risk, non-elective procedure, in-stent restenos
bifurcation, kissing stents, “crush” stenting, use of intravascu
balloon counterpulsation, reference vessel diameter, final min
pressure in the parent vessel (max atm PV) or side branc
continuous variables, mean  SD. ‡Parent vessel is defined
artery.
MACE  major adverse cardiac events (death, any m
revascularization.ES implantation (7). Indeed, every case of restenosis in Whe three largest published case series have involved target
esions within the distal LMCA (5–7), the majority of
hich had been treated with stents in both branches.
revious studies report restenosis rates ranging from 2% to
9%, but the proportion of patients in these studies that
ere treated with bifurcation stenting varied from 8% to
4%, respectively (8,10). For example, Chieffo et al. (10)
erformed LMCA intervention with DES in 85 patients; all
2 episodes of TLR that occurred were in the 51 patients that
ad undergone stenting of both limbs of the LMCA, resulting
n a restenosis rate (24%) that approaches our findings.
We found that SES failure was usually due to reste-
osis within the left circumflex ostium. The maximal
alloon pressure used and the final MLD were indepen-
ently associated with restenosis of the parent vessel but
ot for the left circumflex branch. This may be due to
nique characteristics of the left circumflex ostium. For
xample, the left circumflex ostium often contains an
cute bend that may predispose to non-apposition of
tent struts. Conclusions cannot be drawn about the
elative merit of the stenting techniques used because the
ifurcation stent approach was not randomized, the
umber of patients receiving the “crush” was small, and in
ome patients post-crush kissing balloon post-dilation
which may improve outcomes) (11) was not performed.
egardless of the technique used, our findings that the
aximal balloon pressure and final MLD are indepen-
ently associated with restenosis of the parent vessel
mphasize the need for high-pressure stent deployment
nd adequate post-dilation with non-compliant balloons
o ensure the long-term success of the parent vessel when
ndertaking distal LMCA intervention with SES.
The temporal pattern of restenosis after DES for unpro-
ected LMCA disease has not been previously reported. We
ound that while the majority of cases of restenosis occurred
ithin three months of the procedure, significant late loss
ccrued between three- and nine-month follow-up, leading
o restenosis and TLR in an additional five patients (10%).
tors for Adverse Outcomes
End Point Absent Versus Present† p Value
(6.5% vs. 31.6%) 0.049
(17.9  1.6 atm vs. 16.6  2.1 atm) 0.073
(3.6% vs. 31.8%) 0.015
(7.1% vs. 27.3%) 0.073
(11.1% vs. 60.0%) 0.028
(17.7  1.9 atm vs. 16.3  16.3 atm) 0.036
(2.96  0.45 atm vs. 2.54  0.35 mm) 0.040
(20.5% vs. 45.5%) 0.052
ables: age, gender, hypertension, diabetes, peripheral vascular
ion 40%, creatinine clearance (CrCl) 45 ml/min, high
et lesion, calcification, stenting of both limbs of the LMCA
trasound (IVUS) post-stent deployment, use of intra-aortic
uminal diameter (MLD), and the maximal balloon dilation
r categorical variables, data presented as proportions; for
left main coronary artery into the left anterior descending
dial infarction, thrombosis, TLR); TLR  target lesionredic
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SES Implantation for Unprotected Left Main Stenosis February 21, 2006:871–7hree months post-procedure based on earlier experiences of
nprotected LMCA PCI that found an early risk of
ortality within the first two to four months post-
rocedure, possibly due to restenosis (12,13). Given our
ndings of continued incremental late loss, surveillance
ngiography at a single early time point, while disclosing
arly restenosis (e.g., three months), is not sufficient to
xclude the development of later restenosis. Whether fur-
her late loss may occur after nine months is unknown,
lthough no late “catch-up” has been observed in previous
tudies evaluating DES implanted for non-bifurcation le-
ions outside the LMCA (14,15).
Severe renal insufficiency (creatinine clearance 45 ml/
in) was an independent predictor of death, TLR, and
ACE in our study. Renal dysfunction is known to be
ssociated with in- and out-of-hospital mortality after PCI,
ndependent of restenosis (16,17). While a decreased anti-
roliferative effect of sirolimus in patients with renal insuf-
ciency patients can not be excluded, other studies have
ound that SES provide substantial reductions in restenosis
ates outside of the LMCA compared to historical bare
etal controls in such patients (17).
We found that unprotected left main coronary inter-
ention with SES was relatively safe. The majority of the
eaths (four of five patients) were non-cardiac and
nrelated to restenosis. No deaths occurred in patients at
ow-risk for cardiac surgery, although by multivariate
nalysis, cardiac surgical risk was not an independent
redictor of outcome. Acute stent thrombosis occurred in
wo patients (4%), both of whom had kissing stents, and
n neither case was a glycoprotein IIb/IIIa inhibitor used.
ur findings are consistent with a randomized study of
ES treatment for coronary bifurcation lesions that
howed a relatively high rate of early thrombosis in patients
eceiving stents in both branches (3%) (18), reinforcing the
mportance of this significant complication during complex
ntervention. While it is unknown whether more aggressive
se of glycoprotein IIb/IIIa inhibitors may have reduced the
ate of stent thrombosis in our study, it is now our policy to
se glycoprotein IIb/IIIa inhibitors in all unprotected
MCA interventions in the absence of contraindications.
re-procedure loading with clopidogrel may also be pru-
ent.
tudy limitations. This was a single-center, non-
andomized trial with a relatively small number of patients.
e included “all-comers” undergoing implantation of SES
ithin the unprotected LMCA, and therefore any selection
ias should be minimized. Routine non-invasive stress
esting was not performed, so in asymptomatic patients who
nderwent TLR the presence of ischemia cannot be deter-
ined. A 600-mg loading dose of clopidogrel was used
efore PCI in some patients; this dose has not been
pproved by the U.S. Food and Drug Administration, and
s therefore considered “off-label.”
onclusions. Distal left main coronary intervention with
ES is safe. When serial surveillance angiography iserformed, restenosis occurs frequently, is typically focal,
nd involves the left circumflex ostium. Restenosis is
sually silent, and late loss continues to accrue after three
onths, suggesting that longer-term angiographic
ollow-up is necessary. While aggressive balloon dilation
nd stent expansion can optimize the longer-term results
ithin the main vessel of the left main coronary bifurca-
ion, techniques to improve success within the left
ircumflex ostium are required. In the DES era, the
onger-term success of unprotected LMCA intervention,
articularly in the presence of distal disease, remains a
hallenge.
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